Genes, Vol. 11, Pages 1445: Pharmacogenomic Biomarkers and Their Applications in Psychiatry
We present major pharmacogenomic biomarkers and their applications in a variety of psychiatric disorders, such as depression, attention-deficit/hyperactivity disorder (ADHD), narcolepsy, schizophrenia, and bipolar disorder. In addition, we extend the scope into epilepsy, since antiepileptic drugs are widely used to treat psychiatric disorders, although epilepsy is conventionally considered to be a neurological disorder.
Source: Genes - Category: Genetics & Stem Cells Authors: Kam Jeong Tags: Review Source Type: research
More News: ADHD | Bipolar | Brain | Depression | Epilepsy | Genetics | Hyperactivity | Mania | Narcolepsy | Neurology | Psychiatry | Schizophrenia | Sleep Medicine